Healthcare & Medical Investment: Securities Report (Domestic Investment Securities) - 19th Fiscal Period (2024/02/01 - 2024/07/31)
Healthcare & Medical Investment Earns One-Star Rating in 2024 GRESB Assessment
Volume change rate ranking (13:00) - Visacas, Amefutaitsyou, etc. are ranked.
In the volume change rate ranking, you can understand the interest of market participants, such as trends in trading, by comparing the average volume of the past 5 days with the volume on the delivery date. Top volume change rate [As of October 2, 13:32] (comparison with average volume of the past 5 days) Code -> Stock -> Volume -> 5-day average volume -> Volume change rate -> Stock price change rate <3070> Jelly Bee 15073200 31500.64 378.56% 0.2407% <143A>
Healthcare & Medical Investment To Go Ex-Dividend On January 30th, 2025 With 3175 JPY Dividend Per Share
September 14th (Japan Standard Time) - $Healthcare & Medical Investment(3455.JP)$ is trading ex-dividend on January 30th, 2025.Shareholders of record on January 31st, 2025 will receive 3175 JPY
Healthcare & Medical Investment: Financial results presentation materials for the fiscal year ending 2024/7 (19th term)
Healthcare & Medical Investment: Summary of financial results for the fiscal year ending 2024/7 (REIT)